Serum Bone Turnover Markers in Patients with Primary Bone Tumors
Authors:
- Fuxing PeiFPFuxing Pei
- Chongqi TuCTChongqi Tu
- Huaixian ZhangHZHuaixian Zhang
- Xueyong QiuXQXueyong Qiu
- 1 January 2007
- journal article
- Published by S. Karger AG in Oncology
- Vol. 72 (5-6) , 338-342
Abstract
Objectives: It was the aim of this study to investigate parameters of bone turnover such as serum bone-specific alkaline phosphatase (BALP) and N-terminal midfragment of osteocalcin (N-MID), as well as serum C-terminal telopeptide of type I collagen (CTX) in patients with primary bone tumors and to investigate their validity in differentiating malignant from benign bone tumors. Methods: A total of 219 patients with primary bone tumors entered the study. The patients were divided into 2 groups according to their age, including a teenage (10–19 years old) and an adult group (≧20 years old). In each group, the patients were divided into several subgroups (osteosarcoma, benign bone tumors or tumor-like lesions, giant cell tumor, and other primary malignant bone tumors). An age- and gender-matched control population was also studied in each group. Blood samples were taken for measurement of serum BALP, N-MID and CTX. Results: The serum BALP levels in patients with osteosarcoma were significantly higher than those of patients in the other subgroups and the controls, both in the teenage (p = 0.01) and the adult group (p = 0.000). The serum N-MID and CTX levels did not significantly differ among patients of different subgroups and the controls, both in the teenage (p = 0.773 and p = 0.747, respectively) and the adult group (p = 0.163 and p = 0.074, respectively). Conclusions: A high serum BALP level is valuable for the diagnosis of adult osteosarcoma, but its use in the development of a differential diagnosis in the teenage patients is not advised because serum BALP levels are also affected by age, pubertal stage and growth velocity. Both serum N-MID and serum CTX are hardly useful in the differential diagnosis of primary bone tumors.Keywords
This publication has 21 references indexed in Scilit:
- Diagnostic and Prognostic Validity of Serum Bone Turnover Markers in Metastatic Renal Cell CarcinomaJournal of Urology, 2006
- Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluationBritish Journal of Cancer, 2006
- Conclusion: Bone markers in metastatic bone diseaseCancer Treatment Reviews, 2006
- The Relative Use of Eight Collagenous and Noncollagenous Markers for Diagnosis of Skeletal Metastases in Breast, Prostate, or Lung Cancer PatientsCancer Epidemiology, Biomarkers & Prevention, 2006
- Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcomaEuropean Journal of Cancer, 2005
- Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid TumorsJNCI: Journal of the National Cancer Institute, 2005
- Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implicationsInternational Journal of Cancer, 2004
- Biochemical markers of bone turnoverCurrent Opinion in Nephrology and Hypertension, 1999
- Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancerBritish Journal of Cancer, 1997
- Dissociation of bone formation markers in bone metastasis of prostate cancerBritish Journal of Cancer, 1997